top of page
shutterstock_1538718899 crop 3 copy.jpg

We are creating the future of vaccinations and drug delivery through painless, dissolving microneedle patches. 

DendriBio is in pre-clinical development of stable, painless and simple vaccine and drug delivery via novel, dissolving microneedle arrays.
shutterstock_711675304.jpg
shutterstock_126116831.jpg

Microneedle arrays use our skin's own highly evolved and efficient immune response, making transdermal delivery as good or better than intramuscular injection.

MICRONEEDLE ADVANTAGES

Thermostable

10-15 minute painless dissolve time

Self-application
potential

LAB PROTOTYPE
MICRONEEDLE ARRAY
PATCH SHOWN
2 hands copy 3.jpg
Dose sparing opportunity with highly customizable arrays and loading

Novel and scalable
manufacturing
 
MN points 1.jpg

NO SHARPS DISPOSAL

RECONSTITUTION NOT REQUIRED

ELIMINATE COLD CHAIN

​

pandemic reach and readiness

Faster pandemic response with increased vaccination coverage into developing countries.

SCIENTIFIC COLLABORATORS

UC Irvine Institute for Immunology
UNCW Dept. of Chemistry and Biochemistry 
Queens University Belfast
SRI International Biosciences Division
TriLink BioTechnologies

PROOF OF CONCEPT

We have completed proof-of-concept validation in a collaborative university study, and are currently conducting immunogenicity studies with our Dissolving Microneedle Array Technology (DMAT). 

vaccination 3.jpg

COMMERCIALIZATION 

Our precision dispenser-based manufacturing process is scalable to high volume production. Contact us for partnership opportunities.

bottom of page